
Asia Pacific sees fastest growth in global epigenetics market
Thanks to the increasing global footprint of local companies.
The Asia Pacific region is projected to experience the most rapid growth in epigenetics, with the global market expected to reach $4.29b by 2030, according to MarketsandMarkets.
The expansion is attributed to the increasing global footprint of local companies through strategic alliances.
Continuous healthcare infrastructure developments in emerging companies are also driving growth.
“Moreover, there is a heightened emphasis on advancing capabilities in next-generation sequencing, which is further propelling market development in the region,” the report said.